Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach: Anti-EBV Drugs for MS: V. Li et al. - Li, Vivien; McKay, Fiona C.; Tscharke, David C.; Smith, Corey; Khanna, Rajiv; Lechner-Scott, Jeannette; Rawlinson, William D.; Lloyd, Andrew R.; Taylor, Bruce V.; Morahan, Julia M.; Steinman, Lawrence; Giovannoni, Gavin; et al. (CNS Drugs, 2025)